AstraZeneca的疫苗被n个EU国家停止了，打完可能成为脑血栓吴老二。

[lindamy]

15 min ago

Germany's Merkel says she would take AstraZeneca Covid-19 vaccine​

From CNN's Nada Bashir

Michael Sohn/AP

German Chancellor Angela Merkel has said she herself “would get vaccinated with AstraZeneca” when called to get the vaccine, adding that the government’s motto to tackle the coronavirus pandemic is “vaccinate, vaccinate, vaccinate.”

The chancellor's remarks come as Germany recommences its rollout of AstraZeneca’s coronavirus vaccine on Friday, a day after the European Medicines Agency [EMA] reaffirmed that the vaccine is both “safe and effective” in preventing coronavirus and “not associated with an increase in the overall risk of thromboembolic events, or blood clots.”

Speaking during news conference following Berlin’s vaccination summit, Merkel said the government was right to impose a temporary suspension on the rollout of the vaccine in order to guarantee its safety.

 

[lindamy]

2 hr 33 min ago

WHO committee says there is no evidence AstraZeneca vaccine causes blood clots​

From CNN’s Virginia Langmaid

A medical worker prepares an AstraZeneca vaccine in Turin, Italy, on March 19. Marco Bertorello/AFP via Getty Images

Current available data does not indicate that recent reported blood clots following the administration of AstraZeneca’s Covid-19 vaccine are connected to the vaccine, the World Health Organization’s Global Advisory Committee on Vaccine Safety said Friday.

The committee concluded that data “do not suggest any overall increase in clotting conditions such as deep venous thrombosis or pulmonary embolism following administration of Covid-19 vaccines.”

The committee noted that people naturally develop blood clots, and Covid-19 infection can also cause them. It said observed rates of these events have actually been lower than expected. Just because someone suffers a blood clot and was also recently vaccinated does not mean the vaccine caused the clot, the committee said.

“A causal relationship between these rare events has not been established at this time,” said the committee.

The committee says it will continue to review vaccination data and update guidance as necessary. It said health authorities should continue to keep careful watch.

 

[lindamy]

4 hr 55 min ago

French Prime Minister to receive AstraZeneca shot Friday​

From CNN’s Barbara Wojazer in Paris and Rob Picheta in London

French Prime Minister Jean Castex receives the first injection of the AstraZeneca vaccine at the Bégin Army Hospital in Saint-Mandé, France on March 19. Eliot Blondet/Abaca/Sipa USA

French Prime Minister Jean Castex will receive a first dose of the AstraZeneca vaccine on Friday, his office said.

The Prime Minister is 55 years old and is not in any priority group, but said he wanted to “show we can have full trust in the vaccine” during a press conference on Thursday, when he announced France would resume using AstraZeneca in its vaccine rollout.

The vaccination will take place at 2.35 p.m. (9.35 a.m. ET) at the Begin Military hospital near Paris, according to his office.

Earlier on Friday, French junior budget minister Olivier Dussopt said in an interview on Europe 1 that the vaccine program will cost between 3 and 4 billion euros ($3.6-$4.8 billion).

“If there’s one spending that we really should not restrict, it is spending on vaccination,” Dussopt said. “It’s the best investment for our health, for our economy, and for France.”

Leaders in the country, where vaccine hesitancy is high, are working to regain trust in the AstraZeneca Covid-19 shot. An Elabe poll this week found that just 22% of French people have faith in the AstraZeneca vaccine.

British Prime Minister Boris Johnson also said he will receive the AstraZeneca vaccine on Friday. The UK has stood by the shot while European countries paused their rollouts.

 

[向问天]

德国和法国恢复了阿斯利康接种。
没办法，饥不择食了。

 

[lindamy]

德国和法国恢复了阿斯利康接种。
没办法，饥不择食了。

10 hr 59 min ago

Not enough vaccine in Europe to stop third wave, warns German Health Minister​

From CNN’s Fred Pleitgen in Berlin

German Health Minister Jens Spahn, right, and German public health expert Karl Lauterbach arrive for a news conference on March 19, in Berlin. Stefanie Loos/Pool/AFP/Getty Images

There is not enough Covid-19 vaccine in Europe to stop the third wave of coronavirus infections, German Health Minister Jens Spahn said on Friday.

Speaking at a weekly news conference, Sphan warned his country may have to reimpose some restrictions to slow the spread of the virus.

"The rising case numbers may mean that we cannot take further opening steps in the weeks to come. On the contrary, we may even have to take steps backwards," he said.

Infections in Germany are rising, as they are across much of Europe.

The country reported 17,482 new cases earlier on Friday. It has resumed its rollout of the AstraZeneca vaccine, after pausing its use earlier in the week.

 

[向问天]

Infections in Germany are rising, as they are across much of Europe.

越打疫苗感染越多，这是打的哪家的疫苗啊？

 

[布鲁斯南]

越打疫苗感染越多，这是打的哪家的疫苗啊？

肯定不是赵家的。要是都用上赵家疫苗，全世界去年3月就太平了！

 

[向问天]

Denmark Reports 2 Cases Of Blood Clots After AstraZeneca Shot​

The two, both hospital staff members, had both received the AstraZeneca vaccine less than 14 days before getting ill, the authority that runs public hospitals in Copenhagen said.​

Denmark Reports 2 Cases Of Blood Clots After AstraZeneca Shot

Denmark said on Saturday that one person had died and another fell seriously ill with blood clots and cerebral haemorrhage after receiving the AstraZeneca COVID-19 vaccination.

www.ndtv.com

 

[lindamy]

1 hr 8 min ago

South Korea identifies two cases of severe adverse reactions linked to AstraZeneca's Covid-19 vaccine​

From CNN's Gawon Bae in Seoul and CNN's Jamie Gumbrecht

A nurse fills a syringe with the AstraZeneca Covid-19 vaccine at Dobong health care center on February 26 in Seoul, South Korea. Jung Yeon-Je/Pool/Getty Images

South Korean health authorities investigated ten cases of severe adverse reactions and anaphylaxis reported after receiving Covid-19 vaccines and identified two linked to the AstraZeneca vaccine, the Korea Disease Control and Prevention Agency (KDCA) said in a news release on Monday.

A nursing hospital patient in her 40s reported high fever and seizure after receiving the AstraZeneca vaccine and low blood pressure the next day, and a medical worker in her 20s displayed anaphylaxis symptoms seven minutes after getting the AstraZeneca vaccine.

Both individual's conditions improved, KDCA added.

Separately, there were two suspected blood clot cases after receiving the AstraZeneca vaccines in South Korea. One of the two died, but the Covid-19 Vaccine Damage Investigation Committee during KDCA briefing on Monday said the correlation between the vaccine and blood clot is "very low." An investigation is continuing for the other patient, who is currently in good condition.

Meanwhile, it is recommended that South Korea continue to use the AstraZeneca vaccine, just as the World Health Organization, European Medicines Agency, and UK Medicines & Healthcare products Regulatory Agency have.

Starting on March 23, nursing hospital workers and patients over 65 will receive the AstraZeneca vaccine. According to the Covid-19 Vaccine Administration Committee's vaccination management system, 76.9% of 375,061 nursing hospital & facility workers and patients over 65 said they will get the vaccine, the KDCA press release added.

In South Korea, a total of 676,607 people have received the first dose of the Covid-19 vaccine so far; 619,100 of those received the AstraZeneca vaccine, according to KDCA press release. A total of 9,703 adverse reactions after receiving a Covid-19 vaccine have been reported as of Monday — 9,592 had common symptoms, 89 had suspected anaphylaxis, six had severe reactions and 16 were deaths.

The committee has so far reviewed 15 of the 16 reported deaths that followed AstraZeneca vaccination and said that it is difficult to recognize the link between 13 deaths and the vaccine; two cases will be reviewed after autopsy.

 

[春夏秋鼕]

AstraZeneca may have included outdated information in Covid vaccine trial, U.S. health agency says

The statement comes just one day after the findings of a large U.S. trial showed the Oxford-AstraZeneca vaccine was safe and highly effective.

www.cnbc.com

• The Data Safety Monitoring Board “expressed concern that AstraZeneca may have included outdated information from that trial,” the U.S. National Institute of Allergy and Infectious Diseases said in a statement.
• The NIAID is led by White House Chief Medical Advisor Dr. Anthony Fauci and is part of the National Institutes of Health.

 

[飞来客]

吴老二是谁？

就是说你没有老二了。

 

[茶马盐铁]

就是说你没有老二了。

别胡说， 你不是活得好好的嘛。

 

[lindamy]

BREAKING NEWS

New AstraZeneca report says vaccine was 76% effective in preventing Covid-19 symptoms​

 

[billwanhua]

BREAKING NEWS

New AstraZeneca report says vaccine was 76% effective in preventing Covid-19 symptoms​

79%--->76% 依然不错。为什么要搞数据操作“data cherry-picking”
最重要的“100% effective against severe disease and hospitalization.”。这个疫苗不错，两个mRNA疫苗也没有100%

The findings suggest the vaccine is more effective in patients aged 65 and older than previously understood, with a newly reported efficacy rate of 85% for that population, up from a previously stated 80%.

AstraZeneca revises Covid vaccine data with lower efficacy rate after accuracy questions

The company now says its vaccine is 76% effective in protecting against symptomatic cases of virus.

www.cnbc.com

如果这个是真的，这个疫苗我排在第一个选择

说不定这个疫苗反而是好疫苗，由于政治原因，被美国和欧洲拿到放大镜下审查，问题起码不会比俩个mRNA 疫苗大，我们谁听过欧美对那俩个疫苗的质疑？

 

[lindamy]

3 hr 2 min ago

"One mistake after the other." How AstraZeneca went from pandemic hero to villain​

From CNN Business' Julia Horowitz in London

After teaming up with Oxford University, AstraZeneca produced a safe and effective Covid-19 vaccine in just nine months, a huge achievement that will help end the pandemic. But a series of missteps along the way has led to scathing criticism from policymakers and health officials, tarnishing the company's image as a hero of the coronavirus era.

The Anglo-Swedish drugmaker mistakenly gave some volunteers a half dose of the vaccine during clinical trials, and it has been criticized for omitting crucial information from its public statements. US regulators have questioned the accuracy of its vaccine data, and severe production delays in Europe have resulted in a political firestorm and a breakdown in relations with EU leaders.

"What we have with AstraZeneca is a company that is not straightforward, that cannot be relied upon," Philippe Lamberts, a Belgian member of the European Parliament, said in a radio interview with the BBC on Wednesday.

AstraZeneca's (AZN) failure to deliver tens of millions of promised doses to the European Union, which is struggling to roll out vaccination programs, led the bloc to impose export restrictions that have already prevented at least one shipment of vaccines to Australia. Leaders could move to make the restrictions even tighter Thursday.

Meanwhile, the US National Institute of Allergy and Infectious Diseases expressed concerns earlier this week that AstraZeneca had presented "outdated" data from a trial of the vaccine's effectiveness. Dr. Anthony Fauci, the agency's director, called it "an unforced error" that could erode trust in a "very good vaccine."

AstraZeneca updated its data on Thursday, reporting that the trials showed its vaccine to be 76% effective in preventing Covid-19 symptoms. Earlier this week, it had said its shot was 79% effective. The rare rebuke from US regulators was a major blow to the company's credibility.

"They've made one mistake after the other," said Jeffrey Lazarus, head of the health systems research group at the Barcelona Institute for Global Health.
Read more:


RELATED

'One mistake after the other.' How AstraZeneca went from pandemic hero to villain​